Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana
Author(s) -
Roger Shapiro,
Michael D. Hughes,
Anthony Ogwu,
Douglas Kitch,
Shahin Lockman,
Claire Moffat,
Joseph Makhema,
S. Moyo,
Ibou Thior,
Kenneth McIntosh,
Erik van Widenfelt,
Jean Leidner,
Kathleen M. Powis,
Aida Asmelash,
Esther Tumbare,
Sheryl Zwerski,
Usha Sharma,
Edward Handelsman,
K. Mburu,
Oluwemimo Jayeoba,
E. Moko,
Sajini Souda,
E. Lubega,
M J Akhtar,
Carolyn Wester,
R. Tuomola,
Wendy Snowden,
Marisol MartinezTristani,
Loeto Mazhani,
Max Essex
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0907736
Subject(s) - nevirapine , lamivudine , zidovudine , medicine , abacavir , reverse transcriptase inhibitor , protease inhibitor (pharmacology) , lopinavir , nelfinavir , ritonavir , pregnancy , breast feeding , virology , viral load , sida , pediatrics , viral disease , biology , virus , antiretroviral therapy , hepatitis b virus , genetics
The most effective highly active antiretroviral therapy (HAART) to prevent mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) in pregnancy and its efficacy during breast-feeding are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom